DH
Definitive Healthcare Corp
0.9663$
-0.4%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 20.6% | 20.8% | 20.9% | 25.9% | 31.2% | 34.0% | 33.8% | 32.4% | 32.6% | 35.0% | 45.3% | 48.3% | |
| 4.3% | 7.2% | 5.9% | 8.5% | 11.6% | 9.7% | 13.1% | 10.5% | 14.3% | 22.2% | 30.6% | 34.4% | |
| 16.9% | 16.9% | 16.3% | 20.8% | 25.8% | 26.6% | 24.8% | 23.9% | 24.6% | 24.6% | 34.6% | 37.0% | |
| 2.3% | 3.2% | 3.1% | 3.1% | 3.0% | 4.9% | 5.3% | 4.9% | 4.5% | 7.1% | 7.6% | 6.3% | |
| 0.7% | -0.2% | 0.0% | -0.2% | – | – | – | – | – | – | – | – | |
| 59.0% | 58.9% | 59.8% | 50.5% | 41.5% | 36.1% | 26.8% | 28.1% | 28.7% | 26.8% | 0.0% | 0.0% | |
| 18.5% | 17.7% | 17.6% | 21.6% | 24.9% | 27.3% | 35.2% | 35.2% | 34.4% | 33.6% | 45.7% | 44.8% | |
| 33.9% | 34.3% | 34.0% | 37.7% | 41.1% | 44.3% | 46.1% | 46.6% | 48.4% | 48.5% | 63.0% | 62.2% | |
| 8.1% | 9.3% | 9.1% | 10.8% | 12.5% | 14.8% | 19.3% | 19.6% | 20.4% | 21.3% | 27.3% | 26.0% | |
| 0.9% | 0.9% | 0.9% | 1.1% | 1.4% | 1.5% | 1.4% | 1.5% | 1.5% | 1.6% | 2.2% | 2.3% | |
| 0.3% | 0.3% | 0.3% | 0.4% | 0.8% | 1.0% | 1.0% | 1.0% | 1.1% | 0.5% | 1.2% | 0.9% | |
| 13.5% | 13.3% | 13.2% | 16.6% | 19.7% | 21.1% | 20.1% | 20.8% | 20.9% | 21.2% | 29.9% | 30.6% | |
| 47.4% | 47.2% | 47.5% | 45.3% | 42.9% | 40.8% | 39.9% | 39.4% | 37.7% | 38.2% | 28.4% | 29.1% | |
| -11.9% | -12.5% | -13.1% | -31.7% | -49.2% | -58.8% | -92.5% | -98.1% | -101.9% | -106.0% | -178.4% | -185.9% | |
| 6.3% | 6.4% | 6.5% | 8.3% | 9.8% | 10.6% | 13.9% | 13.9% | 13.7% | 14.1% | 20.3% | 21.3% |
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.